Pulse pressure in relation to tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults.
暂无分享,去创建一个
D. Salmon | M. Bondi | D. Galasko | Blake K. Scanlon | S. Edland | K. Bangen | S. D. Han | L. Delano-Wood | E. Edmonds | D. Nation | Douglas R. Galasko | Douglas Galasko | David P. Salmon | Blake K. Scanlon | S. Duke Han
[1] David D. Shin,et al. Elevated cerebrovascular resistance index is associated with cognitive dysfunction in the very-old , 2015, Alzheimer's Research & Therapy.
[2] D. Knopman. β-Amyloidosis and neurodegeneration in Alzheimer disease , 2014, Neurology.
[3] D. Drachman. The amyloid hypothesis, time to move on: Amyloid is the downstream result, not cause, of Alzheimer's disease , 2014, Alzheimer's & Dementia.
[4] C. Jack,et al. Biomarker Modeling of Alzheimer’s Disease , 2013, Neuron.
[5] D. Salmon,et al. Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults , 2013, Neurology.
[6] L. Kuller,et al. Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults , 2013, Neurology.
[7] C. Bulpitt,et al. Increased pulse pressure linked to dementia: further results from the Hypertension in the Very Elderly Trial – HYVET , 2013, Journal of hypertension.
[8] J. Trojanowski,et al. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. , 2013, Brain : a journal of neurology.
[9] D. Salmon,et al. Cortical and subcortical cerebrovascular resistance index in mild cognitive impairment and Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.
[10] J. Weuve,et al. Alzheimer disease in the United States (2010–2050) estimated using the 2010 census , 2013, Neurology.
[11] Denise C. Park,et al. Risk factors for β-amyloid deposition in healthy aging: vascular and genetic effects. , 2013, JAMA neurology.
[12] C. Jack,et al. Brain injury biomarkers are not dependent on β‐amyloid in normal elderly , 2013, Annals of neurology.
[13] C. Jack,et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.
[14] E. Siegel,et al. Interactive relations of blood pressure and age to subclinical cerebrovascular disease , 2012, Journal of hypertension.
[15] H. Braak,et al. Where, when, and in what form does sporadic Alzheimer's disease begin? , 2012, Current opinion in neurology.
[16] David A Wolk,et al. Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. , 2012, Brain : a journal of neurology.
[17] Sterling C. Johnson,et al. CSF T-Tau/Aβ42 Predicts White Matter Microstructure in Healthy Adults at Risk for Alzheimer’s Disease , 2012, PloS one.
[18] C. Jack,et al. An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer disease , 2012, Annals of neurology.
[19] A. Fleisher,et al. Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons , 2012, Neurobiology of Aging.
[20] Wendy J Mack,et al. Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review , 2011, Alzheimer's Research & Therapy.
[21] B. Zlokovic. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.
[22] V. Gudnason,et al. Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene/Environment Susceptibility--Reykjavik study. , 2011, Brain : a journal of neurology.
[23] N. Wong,et al. The significance of low DBP in US adults with isolated systolic hypertension , 2011, Journal of hypertension.
[24] D. Knopman,et al. Vascular risk factors: imaging and neuropathologic correlates. , 2010, Journal of Alzheimer's disease : JAD.
[25] C. Jack,et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.
[26] S. Leurgans,et al. The neuropathology of probable Alzheimer disease and mild cognitive impairment , 2009, Annals of neurology.
[27] R. Petersen,et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects , 2009, Annals of neurology.
[28] R. Weller,et al. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy , 2009, Acta Neuropathologica.
[29] Julian F. Thayer,et al. Pulse Pressure and Pulse Wave Velocity Are Related to Cognitive Decline in the Baltimore Longitudinal Study of Aging , 2008, Hypertension.
[30] G. de Simone,et al. High pulse pressure as a marker of preclinical cardiovascular disease. , 2006, Future cardiology.
[31] R. Devereux,et al. Is High Pulse Pressure a Marker of Preclinical Cardiovascular Disease? , 2005, Hypertension.
[32] B. Lernfelt,et al. 15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.
[33] R B D'Agostino,et al. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. , 1994, Stroke.